| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AXIM BIOTECHNOLOGIES, INC. | Chief Financial Officer | Convertible Note | 3,475,000 | 15 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AXIM | AXIM BIOTECHNOLOGIES, INC. | 15 Mar 2024 | 1 | +$2,862,250,000 | 4 | Chief Financial Officer | 19 Mar 2024, 19:16 |
| AXIM | AXIM BIOTECHNOLOGIES, INC. | 23 Sep 2022 | 1 | $0 | 4 | Chief Financial Officer | 23 Sep 2022, 16:33 |
| AXIM | AXIM BIOTECHNOLOGIES, INC. | 10 Dec 2020 | 1 | $0 | 4 | Chief Financial Officer | 23 Sep 2022, 16:31 |